Australian pharmaceutical company Amplia Therapeutics (ASX: ATX) is conducting a clinical trial—the ACCENT trial—for pancreatic cancer. The trial will test…
At a time when sustainability and independence have become foundational to companies everywhere, battery tech company Novonix (ASX: NVX) is…